Cancer treatment has roughly 200 FDA-approved biomarker-drug combinations, and that number keeps climbing like a startup's Series B pitch deck. No oncologist - no matter how caffeinated - can keep all of that in their head. So naturally, everyone's building AI to help. But here's where it gets...
A robot in Toronto just out-chemisted an entire field of lipid researchers, and nobody told it where to look.
A chatbot dressed up as history's most famous physicist just walked into classrooms around the world, and educators are having the kind of heated arguments usually reserved for faculty meetings about coffee budgets. Meet the "Einstein" bot - an AI tutor that's apparently smart enough to explain...
Most drug discovery starts with a target - a protein that misbehaves, a receptor that needs blocking, a lock that needs a very specific molecular key. But what if you skipped all that and just told the computer, "Hey, see how this disease messes up thousands of genes at once? Find me a molecule...
Somewhere in Cordoba, Spain, a computer just told thousands of women their mammograms looked normal - and it was better at the job than anyone expected. A team led by Esperanza Elías-Cabot ran a prospective clinical trial with 31,301 women and found that an AI system could handle roughly two-thirds...
Nearly half your genome is made of transposable elements - ancient viral hitchhikers that copy-pasted themselves across your DNA millions of years ago. Biologists used to call them "junk DNA," which, in hindsight, was like calling the quiet kid in class harmless right before they flip the table. A...